Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Thyroiditis (subacute De Quervain, postpartum, on immunotherapy)

Endocrinology and metabolism · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: Postpartum thyroiditis: 3 to 8% of pregnancies [1]

Painful thyroid (subacute thyroiditis)

Laboratory tests

Later, after the painful phase

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

After childbirth (postpartum thyroiditis)

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

On cancer immunotherapy

Before the first injection, then before each course (first 3 to 6 months)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (13)
  1. Inaba H, Akamizu T. Postpartum thyroiditis. In: Feingold KR, Adler RA, Ahmed SF, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com; mise à jour du 8 mai 2018 (synthèse d'expert, pas une recommandation).
  2. Haute Autorité de santé. Prise en charge des hyperthyroïdies en population générale. Recommandation de bonne pratique (fiche mémo), validée par le Collège le 15 décembre 2022.
  3. Hennessey JV. Subacute thyroiditis. In: Feingold KR, Adler RA, Ahmed SF, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com; mise à jour du 7 janvier 2026 (synthèse d'expert, pas une recommandation).
  4. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1208 et 1211 (TSH, TSH + T4L), 1487 (anticorps anti-TPO) et 1488 (anticorps anti-récepteurs de la TSH).
  5. National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guideline NG145, 2019, mise à jour en 2023.
  6. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.
  7. Sweeney LB, Stewart C, Gaitonde DY. Thyroiditis: an integrated approach. Am Fam Physician. 2014;90(6):389-396.
  8. Haute Autorité de santé. Prise en charge des hypothyroïdies chez l'adulte. Recommandation de bonne pratique, validée par le Collège en décembre 2022.
  9. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389.
  10. Illouz F, Drui D, Caron P, Do Cao C. Expert opinion on thyroid complications in immunotherapy (avis d'experts de la Société française d'endocrinologie). Ann Endocrinol (Paris). 2018;79(5):555-561.
  11. Husebye ES, Castinetti F, Criseno S, et al. Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. Eur J Endocrinol. 2022;187(6):G1-G21.
  12. Higham CE, Olsson-Brown A, Carroll P, et al. Society for Endocrinology Endocrine Emergency Guidance: Acute management of the endocrine complications of checkpoint inhibitor therapy. Endocr Connect. 2018;7(7):G1-G7.
  13. Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-1768.